Why do marijuana and synthetic cannabimimetics induce acute myocardial infarction in healthy young people?

J Weresa, A Pędzińska-Betiuk, K Mińczuk… - Cells, 2022 - mdpi.com
The use of cannabis preparations has steadily increased. Although cannabis was
traditionally assumed to only have mild vegetative side effects, it has become evident in …

Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology

GAM Barros, AM Pos, ÂM Sousa, CL Pereira… - Brazilian Journal of …, 2024 - SciELO Brasil
There is growing interest in using cannabinoids across various clinical scenarios, including
pain medicine, leading to the disregard of regulatory protocols in some countries …

[HTML][HTML] Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies

N Theerasuwipakorn, S Prechawat… - Toxicology Reports, 2023 - Elsevier
Background Cannabis is the most used illicit drug in the world. Global trends of
decriminalization and legalization of cannabis lead to various forms of cannabis use and …

Efeitos adversos do uso dos canabinoides: qual o paradigma de segurança?

JBS Garcia, JO Barbosa Neto - BrJP, 2023 - SciELO Brasil
RESUMO JUSTIFICATIVA E OBJETIVOS: O interesse na utilização da maconha (Cannabis
sativa) com fins medicinais aumentou de forma exponencial nas últimas décadas e a planta …

[HTML][HTML] Prevalence, Perceptions, and Patterns of Cannabis Use Among Cardiac Inpatients at a Tertiary-Care Hospital: A Cross-Sectional Survey

KL Walker, SA Mackler, SM Noble, AE Gaudreault… - CJC open, 2023 - Elsevier
Background Cannabis use may adversely affect cardiovascular health. Patterns of use by
cardiac patients are unknown. We evaluated the prevalence, perceptions, and patterns of …

Can Marijuana Use Lead to Cerebral Ischemia?

F Akbik, O Sadan - Stroke, 2022 - Am Heart Assoc
The active ingredient of marijuana Δ9-tetrahydrocannabinol mediates its psychoactive
effects via cannabinoid receptors (CB1 [cannabinoid receptor 1] and CB2 [cannabinoid …

Analysis of safety concerns regarding the use of phytoestrogencontaining products

AM Tjeerdsma, F van Hunsel, S van de Koppel… - Drug …, 2023 - search.proquest.com
Abstract Introduction: Phytoestrogens (PEs) are able to interact with estrogen receptors and
can therefore modulate gene expression. Plant products containing PEs are used for various …

Safety evaluation of cannabis preparations for medical use in Italy

I Ippoliti, F Menniti-Ippolito, R Da Cas - Drug Safety, 2023 - search.proquest.com
Background: Cannabis (eg Cannabis sativa L.) has been traditionally used for medical
purposes particularly for nausea, chronic pain, and neurological disorders [1, 2]. In Italy …

[HTML][HTML] Adverse effects of cannabinoid use: what is the safety paradigm?

JBS Garcia, JO Barbosa Neto - BrJP, 2023 - SciELO Brasil
HIGHLIGHTS The evidence is still contradictory and weak on many aspects of adverse
effects. Increased knowledge about the extraction, purification, and synthesis of …

[PDF][PDF] Risque de troubles dépressifs associés à l'utilisation médicale du cannabis: une étude de cohorte longitudinale rétrospective

J Liwono Yana - 2023 - corpus.ulaval.ca
Résumé Compte tenu de l'usage croissant du cannabis médical pour des raisons, entre
autres, de soulager les symptômes dépressifs, alors que les évidences sur l'innocuité du …